IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Stonepine Capital Management, LLC

Q2 2024 Holdings

Filed 2024-08-13 | 25 holdings | $109.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2024-08-21) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc(ADMA)COM000899104$20.9M1,870,00019.1%
Alimera Sciences IncCOM NEW016259202$19.5M3,511,81617.8%
Evolus Inc(EOLS)COM30052C107$18.0M1,657,61116.4%
Galapagos NV(GLPG)SPONS ADR36315X101$12.0M485,00011.0%
Revance Therapeutics Inc(RVNCEUR)COM761330109$7.2M2,800,0006.6%
Xoma Corp(XOMA)COM NEW98419J206$5.9M250,1295.4%
Anika Therapeutics Inc(ANIK)COM035255108$4.2M165,3973.8%
Tela BIO Inc(TELA)COM872381108$2.9M625,6452.7%
Rigel Pharmaceuticals Inc(RIGL)COM NEW766559702$2.5M305,0002.3%
Optinose IncCOM68404V100$2.4M2,350,0102.2%
Aclaris Therapeutics Inc(ACRS)COM00461U105$2.1M1,927,4461.9%
Scpharmaceuticals Inc(SCPH)COM810648105$1.8M421,7031.7%
Aurinia Pharmaceuticals Inc(AUPH)COM05156V102$1.7M300,0001.6%
Milestone Pharmaceuticals in(MIST)COM59935V107$1.6M1,239,1991.5%
Aytu Biopharma Inc(AYTU)COM054754858$1.4M472,4691.3%
Kiora Pharmaceuticals IncCOM NEW49721T309$840.0K200,0000.8%
Adicet BIO Inc(TORCEUR)COM007002108$737.4K609,4460.7%
Surrozen Inc(SRZN)ACOM NEW86889P208$723.6K66,0840.7%
Exagen Inc(XGN)COM30068X103$652.8K358,6970.6%
Kezar Life Sciences IncCOM49372L100$630.3K1,050,4520.6%
Aprea Therapeutics Inc(APRE)COM NEW03836J201$558.3K137,1740.5%
2Seventy BIO Inc(TSVT*)COM901384107$385.0K100,0000.4%
Eton Pharmaceuticals Inc(ETON)COM29772L108$361.9K110,0000.3%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$313.0K48,0120.3%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$81.3K5,0000.1%